| Product Code: ETC13155514 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Premenstrual Dysphoric Disorder Market was valued at USD 0.5 Billion in 2024 and is expected to reach USD 0.7 Billion by 2031, growing at a compound annual growth rate of 5.80% during the forecast period (2025-2031).
The Global Premenstrual Dysphoric Disorder (PMDD) market is experiencing growth due to increased awareness and diagnosis of the condition, as well as the development of novel treatment options. The market includes pharmaceuticals such as selective serotonin reuptake inhibitors (SSRIs), hormonal therapies, and over-the-counter remedies. Additionally, behavioral therapies and lifestyle modifications are gaining traction as complementary treatments. Key players in the market are investing in research and development to introduce innovative therapies, while collaborations and partnerships are on the rise to enhance product offerings and expand market reach. Factors such as the growing female population, rising healthcare expenditure, and improving healthcare infrastructure in developing countries are expected to drive market growth in the coming years. Furthermore, efforts to destigmatize mental health conditions like PMDD are also contributing to market expansion.
The Global Premenstrual Dysphoric Disorder (PMDD) market is witnessing significant growth due to increasing awareness about the condition and growing research efforts to develop effective treatments. The market is expected to be driven by the rising prevalence of PMDD among women worldwide, leading to a higher demand for therapies that can effectively manage the symptoms. Opportunities in the market include the development of innovative pharmaceuticals and non-pharmacological interventions, as well as the expansion of healthcare infrastructure to provide better access to diagnosis and treatment services for patients. Additionally, collaborations between pharmaceutical companies and research institutions to explore new treatment options and advancements in personalized medicine are likely to shape the future of the PMDD market.
The Global Premenstrual Dysphoric Disorder (PMDD) market faces several challenges, including limited awareness among healthcare providers and the general public about PMDD as a distinct and severe condition. Diagnosis of PMDD is often difficult due to its overlap with other mood disorders, leading to underdiagnosis and undertreatment. Additionally, the lack of specific diagnostic tests for PMDD further complicates accurate identification of the disorder. Limited treatment options and the varying effectiveness of existing therapies also present challenges in managing PMDD symptoms effectively. Furthermore, stigma and misconceptions surrounding menstrual-related mood disorders can hinder open discussions about PMDD and impede access to appropriate care and support for affected individuals. Addressing these challenges will be crucial in improving the diagnosis, treatment, and overall management of PMDD on a global scale.
The Global Premenstrual Dysphoric Disorder (PMDD) market is primarily driven by the increasing awareness and recognition of PMDD as a distinct medical condition among healthcare professionals and patients. The growing prevalence of PMDD, coupled with the rising trend of women seeking treatment for menstrual-related mood disorders, is fueling the demand for effective therapies. Additionally, advancements in medical research and development of novel treatment options, such as selective serotonin reuptake inhibitors (SSRIs) and hormonal therapies, are contributing to market growth. Furthermore, initiatives by government organizations and advocacy groups to improve access to mental health services and promote education about PMDD are expected to further drive the market expansion. Overall, the emphasis on women`s health and well-being is a key factor propelling the growth of the Global PMDD market.
Government policies related to the Global Premenstrual Dysphoric Disorder (PMDD) market focus on improving awareness, diagnosis, and treatment options for individuals affected by this condition. Various governments have implemented initiatives to promote research, education, and public health programs targeting PMDD, aiming to enhance understanding among healthcare professionals and the general public. Additionally, regulatory bodies have been working to streamline the approval process for PMDD treatments and medications, ensuring safe and effective options are available to those in need. Governments are also emphasizing the importance of mental health support and counseling services for individuals suffering from PMDD, highlighting the significance of addressing the psychological impact of this disorder. Overall, government policies aim to address the unique challenges faced by individuals with PMDD and improve their quality of life through comprehensive strategies and interventions.
The Global Premenstrual Dysphoric Disorder (PMDD) market is expected to witness significant growth in the coming years due to increasing awareness about mental health issues and the availability of advanced treatment options. Factors such as the rising prevalence of PMDD among women, the development of novel therapies targeting PMDD symptoms, and the growing acceptance of mental health disorders are driving market expansion. Additionally, collaborations between pharmaceutical companies and research institutions to develop effective medications and therapies for PMDD are likely to boost market growth. However, challenges such as the stigma associated with mental health disorders and the high cost of treatment options may hinder market progress. Overall, the market is poised for growth with a focus on innovative treatment solutions and improved access to care for individuals affected by PMDD.
In the Global Premenstrual Dysphoric Disorder (PMDD) market, Asia is expected to witness significant growth due to increasing awareness and healthcare infrastructure development. North America leads the market with a high prevalence of PMDD cases and advanced treatment options. Europe is also a key region, driven by a growing focus on women`s health and research initiatives. The Middle East and Africa region is anticipated to show steady growth with improving access to healthcare services. Latin America is experiencing a rise in PMDD cases, leading to increased demand for treatment options. Overall, the global PMDD market is poised for growth across all regions, with varying degrees of opportunities and challenges present in each market segment.
Global Premenstrual Dysphoric Disorder Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Premenstrual Dysphoric Disorder Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Premenstrual Dysphoric Disorder Market Revenues & Volume, 2021 & 2031F |
3.3 Global Premenstrual Dysphoric Disorder Market - Industry Life Cycle |
3.4 Global Premenstrual Dysphoric Disorder Market - Porter's Five Forces |
3.5 Global Premenstrual Dysphoric Disorder Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Premenstrual Dysphoric Disorder Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Global Premenstrual Dysphoric Disorder Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.8 Global Premenstrual Dysphoric Disorder Market Revenues & Volume Share, By Symptoms, 2021 & 2031F |
3.9 Global Premenstrual Dysphoric Disorder Market Revenues & Volume Share, By Dosage, 2021 & 2031F |
3.10 Global Premenstrual Dysphoric Disorder Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.11 Global Premenstrual Dysphoric Disorder Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.12 Global Premenstrual Dysphoric Disorder Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Global Premenstrual Dysphoric Disorder Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Premenstrual Dysphoric Disorder Market Trends |
6 Global Premenstrual Dysphoric Disorder Market, 2021 - 2031 |
6.1 Global Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Treatment, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Antidepressants, 2021 - 2031 |
6.1.3 Global Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Nonsteroidal Anti-inflammatory Drugs (NSAIDs), 2021 - 2031 |
6.1.4 Global Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Analgesics, 2021 - 2031 |
6.1.5 Global Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Hormone Therapy, 2021 - 2031 |
6.1.6 Global Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Exercise, 2021 - 2031 |
6.1.7 Global Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Diet, 2021 - 2031 |
6.1.8 Global Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Physical Examination, 2021 - 2031 |
6.2.3 Global Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Global Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Symptoms, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Depression, 2021 - 2031 |
6.3.3 Global Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Intense Anger, 2021 - 2031 |
6.3.4 Global Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Mood Swings, 2021 - 2031 |
6.3.5 Global Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Irritability, 2021 - 2031 |
6.3.6 Global Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 Global Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Dosage, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Tablet, 2021 - 2031 |
6.4.3 Global Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Injection, 2021 - 2031 |
6.4.4 Global Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Others, 2021 - 2031 |
6.5 Global Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.5.3 Global Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Intravenous, 2021 - 2031 |
6.5.4 Global Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Others, 2021 - 2031 |
6.6 Global Premenstrual Dysphoric Disorder Market, Revenues & Volume, By End-Users, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 Global Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Clinic, 2021 - 2031 |
6.6.3 Global Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Hospital, 2021 - 2031 |
6.6.4 Global Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Others, 2021 - 2031 |
6.7 Global Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.7.1 Overview & Analysis |
6.7.2 Global Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Hospital Pharmacy, 2021 - 2031 |
6.7.3 Global Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Retail Pharmacy, 2021 - 2031 |
6.7.4 Global Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Online Pharmacy, 2021 - 2031 |
7 North America Premenstrual Dysphoric Disorder Market, Overview & Analysis |
7.1 North America Premenstrual Dysphoric Disorder Market Revenues & Volume, 2021 - 2031 |
7.2 North America Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Premenstrual Dysphoric Disorder Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Premenstrual Dysphoric Disorder Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Premenstrual Dysphoric Disorder Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.4 North America Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
7.5 North America Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Symptoms, 2021 - 2031 |
7.6 North America Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Dosage, 2021 - 2031 |
7.7 North America Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.8 North America Premenstrual Dysphoric Disorder Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.9 North America Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Latin America (LATAM) Premenstrual Dysphoric Disorder Market, Overview & Analysis |
8.1 Latin America (LATAM) Premenstrual Dysphoric Disorder Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Premenstrual Dysphoric Disorder Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Premenstrual Dysphoric Disorder Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Premenstrual Dysphoric Disorder Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Premenstrual Dysphoric Disorder Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Treatment, 2021 - 2031 |
8.4 Latin America (LATAM) Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
8.5 Latin America (LATAM) Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Symptoms, 2021 - 2031 |
8.6 Latin America (LATAM) Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Dosage, 2021 - 2031 |
8.7 Latin America (LATAM) Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
8.8 Latin America (LATAM) Premenstrual Dysphoric Disorder Market, Revenues & Volume, By End-Users, 2021 - 2031 |
8.9 Latin America (LATAM) Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9 Asia Premenstrual Dysphoric Disorder Market, Overview & Analysis |
9.1 Asia Premenstrual Dysphoric Disorder Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Premenstrual Dysphoric Disorder Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Premenstrual Dysphoric Disorder Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Premenstrual Dysphoric Disorder Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Premenstrual Dysphoric Disorder Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Treatment, 2021 - 2031 |
9.4 Asia Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
9.5 Asia Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Symptoms, 2021 - 2031 |
9.6 Asia Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Dosage, 2021 - 2031 |
9.7 Asia Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
9.8 Asia Premenstrual Dysphoric Disorder Market, Revenues & Volume, By End-Users, 2021 - 2031 |
9.9 Asia Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10 Africa Premenstrual Dysphoric Disorder Market, Overview & Analysis |
10.1 Africa Premenstrual Dysphoric Disorder Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Premenstrual Dysphoric Disorder Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Premenstrual Dysphoric Disorder Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Premenstrual Dysphoric Disorder Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Premenstrual Dysphoric Disorder Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Treatment, 2021 - 2031 |
10.4 Africa Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
10.5 Africa Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Symptoms, 2021 - 2031 |
10.6 Africa Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Dosage, 2021 - 2031 |
10.7 Africa Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
10.8 Africa Premenstrual Dysphoric Disorder Market, Revenues & Volume, By End-Users, 2021 - 2031 |
10.9 Africa Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11 Europe Premenstrual Dysphoric Disorder Market, Overview & Analysis |
11.1 Europe Premenstrual Dysphoric Disorder Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Premenstrual Dysphoric Disorder Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Premenstrual Dysphoric Disorder Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Premenstrual Dysphoric Disorder Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Premenstrual Dysphoric Disorder Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Treatment, 2021 - 2031 |
11.4 Europe Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
11.5 Europe Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Symptoms, 2021 - 2031 |
11.6 Europe Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Dosage, 2021 - 2031 |
11.7 Europe Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
11.8 Europe Premenstrual Dysphoric Disorder Market, Revenues & Volume, By End-Users, 2021 - 2031 |
11.9 Europe Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12 Middle East Premenstrual Dysphoric Disorder Market, Overview & Analysis |
12.1 Middle East Premenstrual Dysphoric Disorder Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Premenstrual Dysphoric Disorder Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Premenstrual Dysphoric Disorder Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Premenstrual Dysphoric Disorder Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Treatment, 2021 - 2031 |
12.4 Middle East Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
12.5 Middle East Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Symptoms, 2021 - 2031 |
12.6 Middle East Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Dosage, 2021 - 2031 |
12.7 Middle East Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
12.8 Middle East Premenstrual Dysphoric Disorder Market, Revenues & Volume, By End-Users, 2021 - 2031 |
12.9 Middle East Premenstrual Dysphoric Disorder Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
13 Global Premenstrual Dysphoric Disorder Market Key Performance Indicators |
14 Global Premenstrual Dysphoric Disorder Market - Export/Import By Countries Assessment |
15 Global Premenstrual Dysphoric Disorder Market - Opportunity Assessment |
15.1 Global Premenstrual Dysphoric Disorder Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Premenstrual Dysphoric Disorder Market Opportunity Assessment, By Treatment, 2021 & 2031F |
15.3 Global Premenstrual Dysphoric Disorder Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
15.4 Global Premenstrual Dysphoric Disorder Market Opportunity Assessment, By Symptoms, 2021 & 2031F |
15.5 Global Premenstrual Dysphoric Disorder Market Opportunity Assessment, By Dosage, 2021 & 2031F |
15.6 Global Premenstrual Dysphoric Disorder Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
15.7 Global Premenstrual Dysphoric Disorder Market Opportunity Assessment, By End-Users, 2021 & 2031F |
15.8 Global Premenstrual Dysphoric Disorder Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
16 Global Premenstrual Dysphoric Disorder Market - Competitive Landscape |
16.1 Global Premenstrual Dysphoric Disorder Market Revenue Share, By Companies, 2024 |
16.2 Global Premenstrual Dysphoric Disorder Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here